CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,494,144 | +418.0% | 91,545 | +323.0% | 0.00% | +200.0% |
| Q2 2023 | $481,490 | -60.5% | 21,640 | -61.6% | 0.00% | -50.0% |
| Q1 2023 | $1,219,848 | +225.4% | 56,318 | +205.1% | 0.00% | +100.0% |
| Q4 2022 | $374,902 | -100.0% | 18,459 | -57.9% | 0.00% | -50.0% |
| Q3 2022 | $1,124,493,000 | +91.7% | 43,857 | +77.8% | 0.00% | +100.0% |
| Q2 2022 | $586,653,000 | -25.3% | 24,670 | -29.2% | 0.00% | 0.0% |
| Q1 2022 | $785,227,000 | -1.0% | 34,868 | -13.0% | 0.00% | 0.0% |
| Q4 2021 | $793,346,000 | -59.3% | 40,068 | -59.5% | 0.00% | -66.7% |
| Q3 2021 | $1,948,812,000 | +114.5% | 99,025 | +139.8% | 0.00% | +200.0% |
| Q2 2021 | $908,336,000 | +19.3% | 41,288 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $761,328,000 | -10.9% | 32,002 | -2.0% | 0.00% | -50.0% |
| Q4 2020 | $854,229,000 | +41.6% | 32,654 | -5.8% | 0.00% | +100.0% |
| Q3 2020 | $603,083,000 | +119.6% | 34,650 | +112.2% | 0.00% | – |
| Q2 2020 | $274,620,000 | -60.2% | 16,327 | -71.8% | 0.00% | -100.0% |
| Q1 2020 | $689,204,000 | +126.4% | 57,965 | +130.4% | 0.00% | 0.0% |
| Q4 2019 | $304,460,000 | +22.2% | 25,162 | +42.7% | 0.00% | – |
| Q3 2019 | $249,186,000 | -54.2% | 17,629 | -63.9% | 0.00% | -100.0% |
| Q2 2019 | $544,298,000 | +105.6% | 48,816 | +116.5% | 0.00% | 0.0% |
| Q1 2019 | $264,749,000 | +779.2% | 22,551 | +900.5% | 0.00% | – |
| Q4 2018 | $30,113,000 | -60.7% | 2,254 | -58.7% | 0.00% | – |
| Q3 2018 | $76,563,000 | -2.0% | 5,461 | +9.9% | 0.00% | – |
| Q2 2018 | $78,113,000 | -84.2% | 4,969 | -83.5% | 0.00% | -100.0% |
| Q1 2018 | $495,523,000 | -28.9% | 30,123 | -21.9% | 0.00% | 0.0% |
| Q4 2017 | $696,827,000 | +294.0% | 38,584 | +321.0% | 0.00% | – |
| Q3 2017 | $176,865,000 | +54.4% | 9,164 | -5.6% | 0.00% | – |
| Q2 2017 | $114,543,000 | +3176.4% | 9,707 | +2942.9% | 0.00% | – |
| Q1 2017 | $3,496,000 | -58.2% | 319 | -72.3% | 0.00% | – |
| Q4 2016 | $8,371,000 | -74.5% | 1,153 | -77.2% | 0.00% | – |
| Q3 2016 | $32,825,000 | +107.1% | 5,050 | +74.0% | 0.00% | – |
| Q2 2016 | $15,850,000 | -72.3% | 2,903 | -74.7% | 0.00% | – |
| Q4 2015 | $57,170,000 | +21.3% | 11,480 | -8.4% | 0.00% | – |
| Q3 2015 | $47,117,000 | +52.3% | 12,531 | +143.4% | 0.00% | – |
| Q2 2015 | $30,945,000 | +341.0% | 5,149 | +310.9% | 0.00% | – |
| Q1 2015 | $7,017,000 | -15.9% | 1,253 | -59.7% | 0.00% | – |
| Q3 2014 | $8,340,000 | +696.6% | 3,112 | +732.1% | 0.00% | – |
| Q2 2014 | $1,047,000 | -52.8% | 374 | -45.7% | 0.00% | – |
| Q4 2013 | $2,219,000 | -90.6% | 689 | -95.4% | 0.00% | – |
| Q3 2013 | $23,620,000 | -41.6% | 14,855 | -36.5% | 0.00% | – |
| Q2 2013 | $40,463,000 | – | 23,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |